SEC Form 3 · accession 0001209191-16-111847
aTYR PHARMA INC · LIFE
Statement of changes in beneficial ownership, as filed. Original on EDGAR ↗
Reporting owner
Sanjay Shukla
Officer — Chief Medical Officer
Period of report
Mar 30, 2016
Accepted (ET)
Apr 1, 2016 · 8:43 pm EDT
Rule 10b5-1 plan
unknown — predates the checkbox
Issuer CIK
0001339970
Table I — non-derivative securities
| Security | Date | Code | Shares | Price | A/D | Owned after | D/I | Nature of ownership |
|---|---|---|---|---|---|---|---|---|
| Common Stock | holding | — | — | — | 3,500 | D |
Table II — derivative securities
No Table II lines on this filing.